Cargando…

Recent Advances in Anti-Angiogenic Therapy of Cancer

Since angiogenesis is critical for tumor growth and metastasis, anti-angiogenic treatment is a highly promising therapeutic approach. Thus, for over last couple of decades, there has been a robust activity aimed towards the discovery of angiogenesis inhibitors. More than forty anti-angiogenic drugs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samant, Rajeev S., Shevde, Lalita A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2011
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260813/ https://www.ncbi.nlm.nih.gov/pubmed/21399234

Ejemplares similares

Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer
por: Meng, Erhong, et al.
Publicado: (2016)

The Hedgehog Pathway Conditions the Bone Microenvironment for Osteolytic Metastasis of Breast Cancer
por: Das, Shamik, et al.
Publicado: (2012)

The Impact of Hedgehog Signaling Pathway on DNA Repair Mechanisms in Human Cancer
por: Meng, Erhong, et al.
Publicado: (2015)

NMI and EMT
por: Samant, Rajeev S., et al.
Publicado: (2014)

Retraction: Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer
por: Meng, Erhong, et al.
Publicado: (2023)

Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance
por: Elhamamsy, Amr R., et al.
Publicado: (2022)

The Influence of the Cancer Microenvironment on the Process of Metastasis
por: Frost, Andra R., et al.
Publicado: (2012)

N-Myc and STAT Interactor regulates autophagy and chemosensitivity in breast cancer cells
por: Metge, Brandon J., et al.
Publicado: (2015)

Micro-RNA-632 down regulates DNAJB6 in breast cancer
por: Mitra, Aparna, et al.
Publicado: (2012)

INCREASED VASCULARITY AND SPONTANEOUS METASTASIS OF BREAST CANCER BY HEDGEHOG SIGNALING MEDIATED UPREGULATION OF CYR61
por: Harris, Lillianne G., et al.
Publicado: (2011)

Hedgehog Signaling in Tumor Cells Facilitates Osteoblast-Enhanced Osteolytic Metastases
por: Das, Shamik, et al.
Publicado: (2012)

Anti-angiogenic therapies for advanced esophago-gastric cancer
por: Fontana, Elisa, et al.
Publicado: (2014)

Hypoxia re-programs 2′-O-Me modifications on ribosomal RNA
por: Metge, Brandon J., et al.
Publicado: (2020)

Angiogenic signaling pathways and anti-angiogenic therapy for cancer
por: Liu, Zhen-Ling, et al.
Publicado: (2023)

Merlin deficiency alters the redox management program in breast cancer
por: Mota, Mateus, et al.
Publicado: (2021)

Spheroid-forming subpopulation of breast cancer cells demonstrates vasculogenic mimicry via hsa-miR-299–5p regulated de novo expression of osteopontin
por: Shevde, Lalita A, et al.
Publicado: (2010)

Hedgehog signaling: modulation of cancer properies and tumor mircroenvironment
por: Hanna, Ann, et al.
Publicado: (2016)

Merlin regulates signaling events at the nexus of development and cancer
por: Mota, Mateus, et al.
Publicado: (2020)

Inhibition of Hedgehog signaling reprograms the dysfunctional immune microenvironment in breast cancer
por: Hanna, Ann, et al.
Publicado: (2018)

Biomarkers for Anti-Angiogenic Therapy in Cancer
por: Wehland, Markus, et al.
Publicado: (2013)

Recent advances of nanomaterial-based anti-angiogenic therapy in tumor vascular normalization and immunotherapy
por: Xiao, Mingshu, et al.
Publicado: (2022)

Future options of anti-angiogenic cancer therapy
por: Cao, Yihai
Publicado: (2016)

Angiogenesis and Anti-Angiogenic Therapy in Gastric Cancer
por: Nienhüser, Henrik, et al.
Publicado: (2017)

Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers
por: Olejarz, Wioletta, et al.
Publicado: (2020)

Nephrotoxicity of Anti-Angiogenic Therapies
por: Van Wynsberghe, Margaux, et al.
Publicado: (2021)

Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer
por: Mitra, Aparna, et al.
Publicado: (2008)

Tumor angiogenesis and anti-angiogenic gene therapy for cancer
por: Li, Tinglu, et al.
Publicado: (2018)

Resistance to Anti-Angiogenic Therapy in Cancer—Alterations to Anti-VEGF Pathway
por: Itatani, Yoshiro, et al.
Publicado: (2018)

Hedgehog signaling enables repair of ribosomal DNA double-strand breaks
por: Lama-Sherpa, Tshering D, et al.
Publicado: (2020)

Functional characterization of the progestagen-associated endometrial protein gene in human melanoma
por: Ren, Suping, et al.
Publicado: (2010)

Loss of tumor suppressor Merlin results in aberrant activation of Wnt/β-catenin signaling in cancer
por: Morrow, K. Adam, et al.
Publicado: (2016)

Conditional knockout of N-Myc and STAT interactor disrupts normal mammary development and enhances metastatic ability of mammary tumors
por: Pruitt, Hawley C., et al.
Publicado: (2018)

Anti-angiogenic Therapy in Patients with Advanced Gastric and Gastroesophageal Junction Cancer: A Systematic Review
por: Chen, Li-Tzong, et al.
Publicado: (2017)

Anti-angiogenic therapies in brain metastases
por: Berghoff, Anna S., et al.
Publicado: (2018)

Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics
por: Abdalla, Ahmed M.E., et al.
Publicado: (2018)

Erratum to: ‘Hedgehog signaling: modulation of cancer properties and tumor microenvironment’
por: Hanna, Ann, et al.
Publicado: (2016)

Recent Advances in Lipopolysaccharide Recognition Systems
por: Mazgaeen, Lalita, et al.
Publicado: (2020)

Ribosome biosynthesis and Hedgehog activity are cooperative actionable signaling mechanisms in breast cancer following radiotherapy
por: Metge, Brandon J., et al.
Publicado: (2023)

The promise of anti-angiogenic cancer therapy
por: Oehler, M K, et al.
Publicado: (2000)

Anti-angiogenic therapy for ovarian cancer
por: García García, Yolanda, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uf4g63kl7ovl6k3jpbg8k298hc